Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report

Core Insights - Certara, Inc. announced expected revenue and bookings for the first quarter, reflecting a positive outlook for the company [1] - The company reiterated its 2025 guidance, projecting sales between $415 million and $425 million, with an adjusted EBITDA margin of 30-32% and adjusted EPS of 42-46 cents [2] Financial Performance - Certara reported revenue of $106 million for the first quarter, a 10% increase from $96.7 million in the same period last year, exceeding the consensus estimate of $104.42 million [4] - Software revenue reached $46.4 million, up 18%, while services revenue was $59.6 million, up 4% [4] - Interim Q1 bookings totaled $118 million, a 12% increase, including software bookings of $40.6 million and services bookings of $77.4 million [4] - The company expects adjusted EBITDA of approximately $33-$35 million, representing a growth of 13-20% [4] Strategic Initiatives - Certara is pursuing a strategic evaluation of its regulatory services business and has engaged in preliminary discussions with several external parties [3] - The company launched its Non-Animal Navigator solution aimed at assisting biopharmaceutical companies in transitioning from animal testing [3] Market Reaction - Following the announcements, Certara's stock price increased by 9.14%, reaching $14.10 [3]